Supplementary Data 1 from Efficacy and Safety of Tunlametinib in Adults with Inoperable Neurofibromatosis Type 1–Associated Plexiform Neurofibromas: Phase IIa Trial and Biomarker Research
Open Access
- 17 June 2026
- other
- Published by American Association for Cancer Research (AACR)